Advertisement

Topics

Teva, Regeneron sign deal to develop pain drug

05:15 EDT 22 Sep 2016 | SmartBrief

Teva Pharmaceutical has entered into a deal with Regeneron Pharmaceuticals to obtain partial rights to develop and market fas -More

Original Article: Teva, Regeneron sign deal to develop pain drug

NEXT ARTICLE

More From BioPortfolio on "Teva, Regeneron sign deal to develop pain drug"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...